The trademark NEUTRIDERM was filed by UAS Pharmaceuticals Pty Ltd., a corporation established under the laws of the Commonwealth of Australia (the "Applicant"). The application was published for oppositions on September 27, 2021, and received one opposition filed on November 15, 2021 by FINANCIERE BATTEUR on Likelihood of confusion. the opponent was represented by Brioude, Charlotte and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 15, 2021
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on September 8, 2021.
The Opposition with reference B 003158322 was refused according to Article 8(1)(b) EUTMR with decision issued on December 19, 2022 by the EUIPO.